$0.00
PT-141, also known as Bremelanotide, is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) developed for the investigation of melanocortin receptor signaling. Researchers continue to study its interactions primarily with melanocortin receptors MC3R and MC4R, which are involved in complex neuroendocrine and neurological signaling pathways.
Unlike peptides investigated primarily for tissue regeneration or metabolic research, PT-141 has attracted scientific interest because of its receptor-selective activity within the melanocortin system. Ongoing research seeks to better understand its receptor pharmacology, intracellular signaling mechanisms, and broader role in neurobiological processes.
These represent areas of ongoing scientific research and are not established clinical uses.
Store refrigerated at 2–8°C (36–46°F). Protect from excessive heat, moisture, and direct sunlight. After reconstitution, follow established laboratory handling and storage procedures.
PT-141 has become an important investigational peptide due to its selective interactions with melanocortin receptors and its well-characterized receptor pharmacology. Researchers continue to investigate its role in melanocortin signaling, neuroendocrine communication, and receptor-mediated biological processes, making it a valuable compound in neuroscience and peptide receptor research.
For laboratory research use only. Not for human consumption. This product is intended exclusively for qualified laboratory and scientific research. It is not intended to diagnose, treat, cure, or prevent any disease.